Board of Regents, The University of Texas System;Applied Cardiovascular Solutions, LLC
发明人:
F. Javier Otero,Joseph J. Beaman,Krishnendu Roy,Andrew Zimbroff
申请号:
US16409266
公开号:
US20190357915A1
申请日:
2019.05.10
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.